Such shifts in pathway utilization would be the expected outcome of several purine‐pathway enzyme defects resulting in PMDs, including LND and, potentially, IMPDH2‐related dystonia caused by gain‐of‐function mutations (see Fig 2). This evidence concerns the gene IMPDH2 and Dystonia.